“The SNO Annual Conference is the biggest annual convention focused on neuro-oncology and a super forum for sharing new knowledge on the use of immunotherapy and TTFields therapy inside the procedure of GBM together with our biggest true-earth study up to now and extra insights about the security and efficacy of TTFields therapy,” claimed Frank Leonard, President of Novocure’s U.
find out more Find out more about our organization and our mission by means of tales about patients, our colleagues, our collaborators and our lifestyle. Back about us our story our Management corporate presentation advocacy ESG exterior funding our therapy our goods Optune Gio® Optune Lua® our pipeline our pipeline novocuretrials.
It highlights a adequate expected support along with a degree III expected support advancement (ASA) for using Optune together with TMZ right after operation and radio-chemotherapy in Grownup sufferers with newly diagnosed GBM.
Tumor Treating Fields have proven a steady anti-mitotic influence in our preclinical and medical exploration spanning greater than 20 years.
about us our therapy our goods our pipeline Trader relations Occupations news and media individual-forward Get hold of us
Novocure will choose aspect in displays and symposia through the function and may exhibit a number of posters Discovering the usage of Tumor Managing Fields (TTFields) therapy from the remedy of lung cancer, which includes a whole new write-up-hoc analysis of knowledge from its LUNAR demo in metastatic non-compact cell lung cancer.
com investor relations investor relations household stock data company presentation SEC filings press releases corporate governance careers news and media news and media push package press releases impression gallery affected person-forward affected person-ahead Make contact with us
com investor relations Trader relations dwelling inventory details company presentation SEC filings push releases company governance Occupations information and media news and media press package press releases graphic gallery affected individual-forward patient-ahead Speak to us
Along with our patients, we strive to increase survival in a lot of the most intense kinds of most cancers by acquiring and commercializing our impressive therapy. Find out more about our story, from our founding in Haifa, Israel in 2000 to owning grown into a worldwide oncology company today.
about us our therapy our goods our pipeline Trader relations Occupations information and media patient-forward Get in touch with us
We dream massive. But we also understand that in an effort to attain our aspirations, we must be intentional every day in how we commit our time, Electrical power and assets. drive
about us our therapy our products and solutions our pipeline investor relations Professions news and media client-ahead Make contact with us
The ENGOT-ov50 / GOG-3029 / INNOVATE-three trial enrolled people by using a optimum of five whole prior strains of systemic therapy. An Examination of exploratory subgroups implies a possible survival benefit in clients who received just one prior line of therapy.
Tumor Treating Fields therapy together with standard of care presented a statistically substantial and clinically meaningful 3-thirty day period advancement in median General survival compared to standard of treatment without having included systemic toxicities Tumor Treating Fields therapy along with immune checkpoint inhibitors resulted within an unprecedented 8-month enhancement in median Over-all survival LUNAR is the first period three medical trial in much more than 7 years to show a nervocure é confiavel substantial extension in All round survival in metastatic non-modest cell lung most cancers submit-platinum therapy Data with the LUNAR demo to get offered currently in the 2023 ASCO Once-a-year Assembly Novocure to host Trader conference call at two p.